CCCC Competitors & Alternatives
Compare C4 Therapeutics Inc with similar stocks in the same industry
Biotechnology
CCCC
Main Stock$3.22
Tradestie Score
60
Market Cap
$153.02M
Revenue Growth
1.1%
Analyst Upside
+259.4%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALMS
Alumis Inc. Common Stock
|
$21.15
|
$422.50M | - | 59 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$75.00
|
$410.79M | - | 48 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$8.37
|
$407.71M | - | 51 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.70
|
$386.68M | - | 42 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.47
|
$382.04M | - | 50 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$10.03
|
$371.64M | - | 61 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$28.02
|
$357.51M | - | 57 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.87
|
$354.45M | - | 57 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$27.74
|
$353.70M | - | 47 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.61
|
$350.98M | - | 53 | Compare |
More CCCC Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry